SCHEMBL30294847

SCHEMBL30294847

Cc1cc(Cl)ccc1Nc1ncc(C(F)(F)F)cc1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ HPGD P15428 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ SORT1 Q99523 2/20 0.50
▸ MPO P05164 1/20 0.47
▸ GRIK1 P39086 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ LMNA P02545 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CNR2 P34972 1/20 0.42
▸ DHODH Q02127 4/20 0.42
▸ MAPT P10636 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ TAS2R14 Q9NYV8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22853164 1.00 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2HPGDRAB9ASORT1
SCHEMBL30294412 0.90 SORT1 (0.54) ALDH1A1SORT1MEN1KMT2ALMNA
SCHEMBL22853174 0.90 SORT1 (0.54) ALDH1A1SORT1MEN1KMT2ALMNA
SCHEMBL22853368 0.89 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HPGDRAB9ASORT1
SCHEMBL30294399 0.89 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2HPGDRAB9ASORT1
SCHEMBL22833733 0.87 MKNK2 (0.47) ALDH1A1SMN1; SMN2RAB9ASORT1MPO
SCHEMBL29382196 0.87 MKNK2 (0.47) ALDH1A1SMN1; SMN2RAB9ASORT1MPO
SCHEMBL22833312 0.83 DHODH (0.56) SORT1DHODHTAS2R14HDAC6
SCHEMBL29383420 0.83 DHODH (0.56) SORT1DHODHTAS2R14HDAC6
SCHEMBL22853093 0.82 DHODH (0.47) ALDH1A1SORT1MPOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230103791-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230103791-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS SCN8A, SCN1A, SCN1B ALDH1A1 3102/4885SMN1; SMN2 195/4885HPGD 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback